Patient Home Monitoring Corp. (PHM.V)
-TSXV 0.11 0.00(0.00%) May 15, 1:08PM EDT
| Prev Close: | 0.11 |
|---|
| Open: | N/A |
|---|
| Bid: | 0.09 |
|---|
| Ask: | 0.10 |
|---|
| 1y Target Est: | N/A |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | N/A - N/A |
|---|
| 52wk Range: | 0.05 - 0.14 |
|---|
| Volume: | 10 |
|---|
| Avg Vol (3m): | 10,192 |
|---|
| Market Cap: | 7.09M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | N/A |
|---|
| Div & Yield: | N/A (N/A) |
|---|
Quotes delayed, except where indicated otherwise. Currency in CAD.
Headlines
- Patient Home Monitoring (PHM) Announces it has Expanded Into a New Service Revenue Line by Executing an Agreement With a Top Cardiology PracticeMarketwired(Wed, May 15)
- Patient Home Monitoring (PHM) Announces it has Expanded Into a New Service Revenue Line by Executing an Agreement With a Top Cardiology PracticeMarketwired(Wed, May 15)
- Patient Home Monitoring (PHM) Releases an Updated Presentation in Advance of Meetings to Introduce Robert Kusher, Its CEO to the Canadian Capital MarketsMarketwired(Tue, Mar 26)
- Patient Home Monitoring (PHM) Releases an Updated Presentation in Advance of Meetings to Introduce Robert Kusher, Its CEO to the Canadian Capital MarketsMarketwired(Tue, Mar 26)
- Patient Home Monitoring Announces Expansion into the Retail Pharmacy Channel with a Letter of Intent to Acquire LM Pharmacy Solutions, and the Appointment of LM's CEO, Robert Kusher as CEOMarketwired(Mon, Mar 11)
- Patient Home Monitoring Announces Expansion into the Retail Pharmacy Channel with a Letter of Intent to Acquire LM Pharmacy Solutions, and the Appointment of LM's CEO, Robert Kusher as CEOMarketwired(Mon, Mar 11)
- Patient Home Monitoring (PHM) Announces Agreement with Buchanan Ingersoll & Rooney PC to In-license a Proprietary INR Testing DeviceMarketwired(Tue, Feb 19)
- Patient Home Monitoring (PHM) Announces Agreement with Buchanan Ingersoll & Rooney PC to In-license a Proprietary INR Testing DeviceMarketwired(Tue, Feb 19)
- Patient Home Monitoring (PHM) Announces Expansion Into the Canadian Market for Coumadin Testing With the Engagement of Mario Cortis, CEO of MediSure Canada, as a Strategic ConsultantMarketwired(Wed, Feb 13)
- Patient Home Monitoring (PHM) Announces Expansion Into the Canadian Market for Coumadin Testing With the Engagement of Mario Cortis, CEO of MediSure Canada, as a Strategic ConsultantMarketwired(Wed, Feb 13)
- Patient Home Monitoring (PHM) Announces Vision and Plan for 2013 and Chairman's Letter to ShareholdersMarketwired(Tue, Feb 5)
- Patient Home Monitoring (PHM) Announces Vision and Plan for 2013 and Chairman's Letter to ShareholdersMarketwired(Tue, Feb 5)
- Patient Home Monitoring (PHM) Announces a Profitable First Quarter of Fiscal 2013 with Strong Cash Flow; and Audited Fiscal Year 2012 ResultsMarketwired(Mon, Jan 28)
- Patient Home Monitoring (PHM) Announces a Profitable First Quarter of Fiscal 2013 with Strong Cash Flow; and Audited Fiscal Year 2012 ResultsMarketwired(Mon, Jan 28)
- Patient Home Monitoring (PHM) Announces Third Fiscal Quarter 2012 Results and Conference CallMarketwired(Mon, Aug 27)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 1.73 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
()
: | N/A |
|---|
| Quarterly EPS Est
()
: | N/A |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Patient Home Monitoring Corp. provides home-based monitoring services and supplies for cardiology patients in the United States. The company offers its products and services to patients that take prescription blood thinners, such as Coumadin.
View More 
0.80%